Astrazeneca (AZN)
Burford Capital (BUR)
Vodafone (VOD)
Fresnillo (FRES)
Marstons (MARS)3 May 2024 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Friday broker round-up
Fri, 25th Jan 2019 13:21
(Sharecast News) - Fresnillo: UBS upgrades to buy with a target price of 1,100p.Daily Mail: Berenberg reiterates buy with a target price of 700p.Scapa Group: Berenberg reiterates buy with a target price of 520p.Sureserve Group: Peel Hunt upgrades to buy with a target price of 40p.Restaurant Group: Liberum reiterates hold with a target price of 180p.Burford Capital: Liberum reiterates buy with a target price of 2,300p.Astrazeneca: Shore Capital Markets downgrades to buy.Marston's: Canaccord reiterates hold with a target price of 105p.Quixant: Canaccord reiterates buy with a target price of 440p.Vodafone: RBC Capital Markets reiterates underperform with a target price of 144p.Connect Group: Berenberg reiterates hold with a target price of 40p.International Consolidated Airlines: Berenberg reiterates buy with a target price of 780p.
Related Shares
More News
3 May 2024 11:50
Angle shares up on assay development deal with AstraZenaca
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
3 May 2024 07:50
LONDON BRIEFING: InterContinental Hotels makes first-quarter progress
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
2 May 2024 10:04
AstraZeneca notes positive trial results for Calquence treatment
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
2 May 2024 07:45
AstraZeneca reports positive results from blood cancer drug trial
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...